Sakumura et al. reported increased levels of serum sCD163 in patients diagnosed with confirmed sJIA and MAS compared to patients with acute sJIA in the absence of MAS, suggesting a correlation between sCD163 levels and clinical MAS (70). Here, CD163 is linked to macrophage activation syndrome.